We are all aware that we are living in challenging times when it comes to biomedical research,” said Robert Negrin, MD, ASH president, in an interview with HCPLive. On the international front, Negrin has spent significant time in communities where patient care and clinician support inequities are most prevalent. Despite challenges in research funding and systemic health barriers, hematology has continued to advance. Looking Ahead to ASH’s 68th Meeting, With President Robert Negrin, MD. Kuznar W. NIH Research Funding Cuts Would Have Devastating Impact on Hematology.